Total Revenue

4% increase (from $571.4M to $594.8M)

Total Revenue growth reflects an overall improvement in underlying service mix and pricing power compared to Q1 2024. This modest increase builds on the previous period’s revenue base and signals steady volume gains across key segments. " "

Home Health Revenue

4.2% increase (from $364.0M to $379.2M)

Home Health revenue increased by $15.2M, indicating improved patient volume and possibly a more favorable payor mix, building upon the earlier period’s incremental growth. The higher revenue demonstrates successful operational enhancements relative to Q1 2024. " "

Hospice Revenue

2.6% increase (from $201.0M to $206.2M)

Hospice services saw a modest rise of $5.2M, likely driven by incremental increases in Medicare reimbursement and stable admissions, improving upon the slightly lower base of the prior period. The stable performance in this area continues from Q1 2024. " "

High Acuity Care Revenue

47% increase (from $6.4M to $9.4M)

High Acuity Care revenue surged by approximately 47%, reflecting accelerated growth driven by increased admissions and higher revenue per episode. This substantial boost indicates a strategic focus on expanding home recovery and palliative care services, significantly outperforming the modest gains seen in Q1 2024. " "

Net Income

324% increase (from $14.6M to $61.8M)

Net income’s dramatic increase is supported by a combination of a substantial rise in operating income and tighter expense controls, translating into much higher profitability relative to Q1 2024. The improvement reflects both operational leverage and cost efficiencies that built on the previous period’s lower margins. " "

Operating Income

37% increase (from $31.6M to $43.4M)

Operating income improved by $11.8M, driven by a $23M increase in net service revenue, partially offset by higher employee-related costs. This improvement builds on earlier period performance while also benefiting from lower merger-related expenses relative to Q1 2024. " "

Basic Earnings Per Share

324% increase (from $0.44 to $1.86)

EPS rose significantly, mirroring the net income jump. The marked increase in earnings per share reflects stronger profit margins and improved operational performance compared to Q1 2024, reinforcing the impact of higher revenue and tighter cost control. " "

Cash and Cash Equivalents

163% increase (from $108.2M to $284.9M)

Cash and cash equivalents nearly tripled, indicating a robust improvement in liquidity and cash flow management. This strong increase reflects both improved operational cash generation and better financial positioning compared to the much lower cash levels at the end of Q1 2024. " "

Total Current Assets

20% increase (from $526.4M to $633.9M)

Total current assets expanded by approximately $107.5M, showing enhanced working capital and asset base. This growth builds on the previous period’s financial metrics by reflecting the company’s liquidity and strategic investments in short‐term assets relative to Q1 2024. " "